Gladskin's new face cream was created for those who suffer from facial redness and rosacea-prone skin, and the Redness Relief Cream is a first-of-its-kind innovation. The product goes about addressing redness by targeting the microbiome with the power of Gladskin's patented endolysin technology, Micreobalance. This patented technology mimics the skin's natural defences to support calm skin and balance at the microbiome level.
According to the brand, "DNA is only partly to blame for irritating facial redness. A controllable trigger of facial redness is in the skin's microbiome, the community of bacteria and microorganisms that live on our skin." The majority of people who experience regular redness don't know or are not sure of the root cause of the problem and this topical cream helps to offer a solution.
Redness Relief Creams
Gladskin's Relief Cream Targets the Root of Redness at the Microbiome
Trend Themes
1. Microbiome-targeted Skincare - There are opportunities for cosmetic companies to innovate by developing microbiome-targeted skincare products.
2. Endolysin Technology in Skincare - There are opportunities for skincare brands to innovate by integrating endolysin technology in their products.
3. Addressing the Root Cause of Facial Redness - There are opportunities for skincare companies to innovate by creating products that address the root cause of facial redness.
Industry Implications
1. Cosmetics Industry - The cosmetics industry could benefit from incorporating microbiome-targeted skincare products.
2. Skincare Industry - The skincare industry has an opportunity to integrate endolysin technology in its products.
3. Dermatology Industry - The dermatology industry could benefit from the development of products that address the root cause of facial redness.